BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10618082)

  • 1. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.
    Polacheck I; Strahilevitz J; Sullivan D; Donnelly S; Salkin IF; Coleman DC
    J Clin Microbiol; 2000 Jan; 38(1):170-4. PubMed ID: 10618082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida dubliniensis candidaemia in an HIV-positive patient in Ireland.
    Boyle BM; Sullivan DJ; Forkin C; Mulcahy F; Keane CT; Coleman DC
    Int J STD AIDS; 2002 Jan; 13(1):55-7. PubMed ID: 11802932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
    Kirkpatrick WR; Revankar SG; Mcatee RK; Lopez-Ribot JL; Fothergill AW; McCarthy DI; Sanche SE; Cantu RA; Rinaldi MG; Patterson TF
    J Clin Microbiol; 1998 Oct; 36(10):3007-12. PubMed ID: 9738058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.
    Jabra-Rizk MA; Falkler WA; Merz WG; Baqui AA; Kelley JI; Meiller TF
    J Clin Microbiol; 2000 Jun; 38(6):2423-6. PubMed ID: 10835022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients.
    Milan EP; de Laet Sant' Ana P; de Azevedo Melo AS; Sullivan DJ; Coleman DC; Lewi D; Colombo AL
    Diagn Microbiol Infect Dis; 2001; 41(1-2):29-35. PubMed ID: 11687311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals.
    Schorling SR; Kortinga HC; Froschb M; Mühlschlegel FA
    Crit Rev Microbiol; 2000; 26(1):59-68. PubMed ID: 10782340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected and non-infected patients and in a yeast culture collection.
    Faggi E; Pini G; Campisi E; Martinelli C; Difonzo E
    Mycoses; 2005 May; 48(3):211-5. PubMed ID: 15842340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Candida dubliniensis in Venezuela.
    Hartung de Capriles C; Mata-Essayag S; Pérez C; Colella MT; Roselló A; Olaizola C; Abate SM
    Mycopathologia; 2005 Oct; 160(3):227-34. PubMed ID: 16205971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
    Moran GP; Sullivan DJ; Henman MC; McCreary CE; Harrington BJ; Shanley DB; Coleman DC
    Antimicrob Agents Chemother; 1997 Mar; 41(3):617-23. PubMed ID: 9056003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV+) subjects.
    Giammanco GM; Pizzo G; Pecorella S; Distefano S; Pecoraro V; Milici ME
    Oral Microbiol Immunol; 2002 Apr; 17(2):89-94. PubMed ID: 11929555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
    Tekeli A; Koyuncu E; Dolapci I; Guven GS; Sahin GO; Uzun O
    Mycoses; 2005 May; 48(3):197-201. PubMed ID: 15842337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Candida dubliniensis in a prospective study of patients in the United States.
    Jabra-Rizk MA; Baqui AA; Kelley JI; Falkler WA; Merz WG; Meiller TF
    J Clin Microbiol; 1999 Feb; 37(2):321-6. PubMed ID: 9889211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
    Jewtuchowicz VM; Mujica MT; Brusca MI; Sordelli N; Malzone MC; Pola SJ; Iovannitti CA; Rosa AC
    Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.
    Ellepola AN; Hurst SF; Elie CM; Morrison CJ
    Oral Microbiol Immunol; 2003 Dec; 18(6):379-88. PubMed ID: 14622344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait.
    Ahmad S; Mokaddas E; Al-Sweih N; Khan ZU
    Med Princ Pract; 2005; 14 Suppl 1():77-83. PubMed ID: 16103717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis.
    Tintelnot K; Haase G; Seibold M; Bergmann F; Staemmler M; Franz T; Naumann D
    J Clin Microbiol; 2000 Apr; 38(4):1599-608. PubMed ID: 10747150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity.
    Sahand IH; Maza JL; Eraso E; Montejo M; Moragues MD; Aguirre JM; Quindós G; Pontón J
    J Med Microbiol; 2009 Nov; 58(Pt 11):1437-1442. PubMed ID: 19608690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study.
    Mokaddas E; Khan ZU; Ahmad S
    Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.